Adult Congenital Heart Disease Pankaj Madan, MD, MS, Medical - - PowerPoint PPT Presentation

adult congenital heart disease
SMART_READER_LITE
LIVE PREVIEW

Adult Congenital Heart Disease Pankaj Madan, MD, MS, Medical - - PowerPoint PPT Presentation

Adult Congenital Heart Disease Pankaj Madan, MD, MS, Medical Director South Texas Adult Congenital Heart Center Methodist Hospital, San Antonio Which statement is FALSE about congenital heart disease population? 1. More children than adults


slide-1
SLIDE 1

Adult Congenital Heart Disease

Pankaj Madan, MD, MS, Medical Director South Texas Adult Congenital Heart Center Methodist Hospital, San Antonio

slide-2
SLIDE 2

Which statement is FALSE about congenital heart disease population?

  • 1. More children than adults have congenital

heart disease.

  • 2. It is the fastest growing population of heart

disorders in adults.

  • 3. >90% of children born with congenital heart

disease reach adulthood.

  • 4. Adults with CHD require specialized care.
slide-3
SLIDE 3

What is TRUE about Adult congenital heart disease care?

  • 1. Most patients are seen in specialized ACHD

clinics

  • 2. Majority of patients are seen by pediatric

cardiologists.

  • 3. Majority of the patients are seeing adult

cardiologists

  • 4. Majority of the patients are lost to follow-up
slide-4
SLIDE 4

What is true about ACHD subspecialty?

  • 1. No specific training. Adult cardiologists are

comfortable in taking care of ACHD patients.

  • 2. No additional training required. Pediatric

cardiologists are qualified to take care of ACHD patients.

  • 3. Additional years of training beyond pediatric
  • r adult cardiology required for expertise in

ACHD care. There is additional board certification.

slide-5
SLIDE 5

ACHD population

  • 40,000 infants born with CHD/ year
  • THE most common birth defect
  • Successful outcome is a moving target

– Surviving initial surgical repair – Surviving to 1 year of age – Normal childhood – Normal adolescence

Survival to adulthood  Survival through adulthood

slide-6
SLIDE 6

Improving survival of CHD patients

20 40 60 80 100 1940 1960 1970 1980 1990 Percent survival to 18 years old Decade born with CHD

slide-7
SLIDE 7

ACHD: Population

Surviving to adulthood is now expected

slide-8
SLIDE 8

Khairy et al. JACC 2010

slide-9
SLIDE 9

Congenital Heart Disease population

70% 30%

Pediatric Adult

1965

slide-10
SLIDE 10

Congenital Heart Disease population

50% 50%

Pediatric Adult

2000

slide-11
SLIDE 11

Congenital Heart Disease population

40% 60%

Pediatric Adult

2010

slide-12
SLIDE 12

Patients reaching Adulthood with CHD

325000 500000 750000 1000000 1400000

200000 400000 600000 800000 1000000 1200000 1400000 1600000

1970 1980 1990 2000 2010

40,000 new patients per year More adults than children with CHD

Gilboa et al. Circulation 2016;134:101–109

slide-13
SLIDE 13

Patients reaching Adulthood with CHD

325000 500000 750000 1000000 1400000

200000 400000 600000 800000 1000000 1200000 1400000 1600000

1970 1980 1990 2000 2010

40,000 new patients per year

55% have moderate to complex CHD

Gilboa et al. Circulation 2016;134:101–109

slide-14
SLIDE 14

PROBLEM

slide-15
SLIDE 15

1 – – 0.9 – – 0.8 – – 0.7 – SCD-Free Survival (proportion) Postoperative Interval (years)

Silka et al. J Am Coll Cardiol . 1998; 32: 245-251.

5 10 15 20 25 30 35

TOF d-TGA

COA

AS

n = 3589

Probability of SCD free survival after surgical correction

slide-16
SLIDE 16

Age at death for adults with CHD

10 15 20 25 30 35 40 Tricuspid atresia TGA CoA N=2609 patients 199 died Mean age at death for all diagnosis 37+/-15 years Oehslin et al. Am J Cardiol 2000; 86: 1111

slide-17
SLIDE 17

Mortality in Adult congenital heart disease

23% 24.50% 14.30% 7.10% 21.90% 9.20%

Non cardiac Heart Failure Vascular Perioperative Arrhythmia Others

Verheugt et al. EHJ 2010; 31: 1220-9

slide-18
SLIDE 18

J Am Coll Cardiol 2007;50:1263–71)

Most of the mortality is cardiac related

slide-19
SLIDE 19

Sudden cardiac death and heart failure leading causes of cardiac mortality

slide-20
SLIDE 20

Morbidity in ACHD

50 100 150 200 250 300 350 400 Severe CHD Mild/moderate CHD Normal population

208

103

354

One year hospitalization rate of patients with severe and other cardiac lesions compared with the adult population of Quebec (April 1999- March 2000) Mackie AS. Am J Cardiol 2007; 99(6): 639-643

slide-21
SLIDE 21

From: The Changing Demographics of Congenital Heart Disease Hospitalizations in the United States, 1998 Through 2010

  • JAMA. 2013;309(10):984-986. doi:10.1001/jama.2013.564
slide-22
SLIDE 22

Patients reaching Adulthood with CHD

325000 500000 750000 1000000 1300000

200000 400000 600000 800000 1000000 1200000 1400000

1970 1980 1990 2000 2010

Once reaching adulthood

  • Survival is not as expected
  • Heart Failure and

arrhythmias

  • Morbidity is substantial
slide-23
SLIDE 23

Long term complications

Adults with Congenital Heart Disease

Arrhythmias

  • Atrial
  • Ventricular
  • SCD

Heart Failure

Residual Shunts Valvular heart disease Vascular lesions

slide-24
SLIDE 24

Long term complications

Adults with Congenital Heart Disease

Arrhythmias

  • Atrial
  • Ventricular
  • SCD

Heart Failure

Residual Shunts Valvular heart disease Vascular lesions

Adult Comorbidities

  • CAD, PVD
  • DM
  • OSA, COPD
  • Renal and Hepatic insufficiency
slide-25
SLIDE 25

Diller et al. Circulation. 2015;132:2118-2125.

slide-26
SLIDE 26

Sudden Cardiac death in ACHD patients

1 2 3 4 5 6 VSD CoA PS TOF D-TGA AS

Incidence / 1000 patient years

Silka et al. JACC 1998: 32: 245

slide-27
SLIDE 27

Prevalence of Atrial arrhythmias in ACHD patients

10 20 30 40 50 60 TOF TGA Aortic stenosis Pulmonary stenosis ASD CoA Fontan Vander Velde et al. Eur J Epidemiol 2005; 20: 549-557

slide-28
SLIDE 28

40 5 10 15 20 25 30 35 Aortic coarction Tetralogy of Fallot VSD Mustard-operation Valvular disease Ebsteins anomaly Pulmonary atresia Fontan-operation ASD (late closure) ccTGA Complex anatomy Eisenmenger ANOVA P<0.0001 Mean ± SD 28.7 ± 10.4 25.5 ± 9.1 23.4 ± 8.9 23.3 ± 7.4 22.7 ± 7.6 20.8 ± 4.2 20.1 ± 6.5 19.8 ± 5.8 19.2 ± 6.2 18.6 ± 6.9 14.6 ± 4.7 11.5 ± 3.6 Peak VO2 (ml s/b mL)

Exercise intolerance in ACHD population

Diller GP, et al. Circulation 2005, 828-835. MVO2 indicates Myocardial Oxygen Consumption; CCTGA, Congenitally Corrected Transposition of the Great Arteries; SD, Septal Defect; ANOVA, Analysis

  • f the Variance; VO2, Volume of Oxygen

12

slide-29
SLIDE 29

ACHD population

  • High risk group of young individuals
  • Requires specialized and

multidisciplinary care.

slide-30
SLIDE 30

30

Who is providing the care?

  • Many being seen by Pediatric Cardiologists NOT

trained in ACHD

  • Many being seen by Adult Cardiologists NOT

trained in ACHD

  • Few being seen in ACHD clinics
  • Several have been lost to follow-up
slide-31
SLIDE 31

31

ACHD Patients in USA vs Those in ACHD Clinics

Number Of Patients

800,000 –

  • 700,000 –
  • 600,000 –
  • 500,000 –
  • 400,000 –
  • 300,000 –
  • 200,000 –
  • 100,000 –
  • 0 –

800,000

Williams RG, et al. J Am Coll Cardiol. 2006;47(4):701-707. ACHA Clinic Directory Working Group 2007

60,000 in ACHD

Krasuski et al. Circulation. 2016;134:110–113

slide-32
SLIDE 32

650 – 520 – 390 – 260 – 130 – 0 –

< 6 Age Group CHD Patients 6-12 13-17 18-22

Diagnosed by cardiologist 643 (100%) n=643 (100%) n=643 (100%) Seen by cardiologist 413 (64%) Seen by cardiologist 292 (45%) Seen by cardiologist 249 (39%) n=466 (72%) n=343 (53%) Attrition 177 (28%) 53 (8%) Attrition 123 (19%) 51 (8%) Attrition 94 (15%) The blue bars indicate patients who were not seen by a cardiologist within the indicated age range but were seen again by a cardiologist in an older age group (ie, transiently lost to follow-up).

Understanding Loss of CHD Follow -Up

Adapted from: Mackie A, et al. Circulation. 2009;120:302-309.

slide-33
SLIDE 33

Reasons for being “Lost”

Patient Obstacles:

  • Patient assumes “cure”
  • Poor communication

from parents or pediatrician

  • Loss of previous health

records

  • Gradual symptom onset

Lack of health insurance

Physician Obstacles:

  • Physician assumes “cure”
  • Uninformed about

specific potential problems

  • No prior records available
  • No reported symptoms
  • Symptoms ascribed to

more common causes

slide-34
SLIDE 34

ACHD clinic: recurring themes

  • Patients not aware of their medical and

surgical history

  • They receive inappropriate medical or

surgical treatment

  • Patients are misinformed.
slide-35
SLIDE 35

Group 1: Simple CHD

  • Unrepaired conditions:

– Isolated small ASD – Isolated small VSD – Mild pulmonic stenosis

  • Repaired conditions:

PDA ASD VSD Repaired or unrepaired conditions

  • Isolated aortic valve

disease

  • Isolated mitral valve

disease

  • Isolated patent foramen
  • vale (PFO)

Patients should be seen at ACHD center at least

  • nce

32nd Bethesda Conference for care of ACHD

slide-36
SLIDE 36

Group 2: Moderately complex CHD

Repaired or Unrepaired:

  • Anomalous Left Coronary Artery from

Pulmonary Artery (ALCAPA)

  • Anomalous pulmonary venous drainage

(partial or total)

  • Atrioventricular (AV) canal/septal defects

(partial or complete)

  • Ostium primum or sinus venosus ASDs.
  • Coarctation of the aorta
  • Ebstein’s anomaly
  • Infundibular right ventricular outflow
  • bstruction (moderate to severe)
  • Pulmonary valve regurgitation

(moderate to severe)

  • Pulmonic valve stenosis (moderate to

severe)

  • Sinus of Valsalva fistula/aneurysm
  • Subvalvar or supravalvar aortic

stenosis

  • Tetralogy of Fallot
  • VSD with any valve problems

Patients should be seen periodically at an ACHD center

32nd Bethesda Conference for care of ACHD

slide-37
SLIDE 37

Group 3: Greatly complex CHD

Repaired or Unrepaired:

  • Congenitally Corrected Transposition
  • f the Great Arteries (ccTGA or l-TGA)
  • Double outlet ventricle
  • Mitral atresia
  • Pulmonary atresia (all forms)
  • Pulmonary vascular obstructive

diseases

  • Shone’s Syndrome
  • Single Ventricle—all forms
  • Transposition of the Great Arteries

(d-TGA)

  • Tricuspid atresia
  • Truncus arteriosus/hemitruncus
  • Other abnormalities of AV

connections (i.e., crisscross heart, isomerism, heterotaxy syndromes) All patients who have undergone the following procedures:

  • Arterial switch procedure
  • Blalock-Taussig shunt
  • Any Conduit(s), valved or nonvalved
  • Double-switch procedure
  • Fontan procedure
  • Mustard procedure
  • Norwood procedure
  • Rastelli procedure
  • Senning procedure

All Patients with Eisenmenger syndrome All Patients who are cyanotic (“blue”)

Patients should be seen regularly at ACHD center.

32nd Bethesda Conference for care of ACHD

slide-38
SLIDE 38

When to refer

  • If your patient had a surgery named after a

physician.

  • When more than one isolated structural defect

is present.

  • You can’t figure out anatomy in 5 seconds
  • Your patient has never been seen by an ACHD

physician

slide-39
SLIDE 39
slide-40
SLIDE 40
slide-41
SLIDE 41
slide-42
SLIDE 42

Additional material

slide-43
SLIDE 43

Transplantation in ACHD

  • Complex anatomy with multiple prior

surgeries

  • Highly sensitized
  • Increased pulmonary vascular resistance
  • Concomitant organ dysfunction e.g. liver
slide-44
SLIDE 44

Transplant outcomes in CHD

slide-45
SLIDE 45

Not all CHD are created equal